Protocol Ledger

NCT06701903 · Phase II · RECRUITING

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Interventional Phase II clinical trial protocol NCT06701903 sponsored by Intra-Cellular Therapies in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-11-21 Enrollment: 570 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06701903
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)570 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06701903
Protocol FieldVerified Registry Value
NCT IdentifierNCT06701903
Consolidated Lead SponsorIntra-Cellular Therapies
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment570 participants (ESTIMATED)
Registered Start Date2024-11-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06701903
Hospital Research SiteLocationSite Profile
University of Alabama at BirminghamBirmingham, ALOpen Hospital Dossier ->
ProScience Research GroupCulver City, CAOpen Hospital Dossier ->
Excell Research IncOceanside, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI